Inducing tolerance to MHC-matched allogeneic islet grafts in Diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy-Reference-Cited by-同舟云学术

Inducing tolerance to MHC-matched allogeneic islet grafts in Diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy

Published:2002-07 Issue:1 Volume:74 Page:22-27
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Wu Tao,Levay-Young Brett,Heuss Neal,Sozen Hakan,Kirchhof Nicole,Sutherland David E. R.,Hering Bernhard,Guo Zhiguang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference33 articles.

1. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen

2. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

3. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

4. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

5. Mixed Chimerism as an Approach to Transplantation Tolerance

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation;Frontiers in Immunology;2021-01-29

2. Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant;The Journal of Clinical Endocrinology & Metabolism;2016-05

3. Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin;PLoS ONE;2013-06-06

4. Endogenous Expansion of Regulatory T Cells Leads to Long-Term Islet Graft Survival in Diabetic NOD Mice;American Journal of Transplantation;2012-02-02

5. Therapeutic plasticity of stem cells and allograft tolerance;Cytotherapy;2011-07